Cargando…
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study
RATIONALE: Malignant pleural mesothelioma (MPM) is mainly caused by previous exposure to asbestos fibers and has a poor prognosis. Due to a long latency period between exposure and diagnosis, MPM incidence is expected to peak between 2020-2025. Screening of asbestos-exposed individuals is believed t...
Autores principales: | Lamote, Kevin, Brinkman, Paul, Vandermeersch, Lore, Vynck, Matthijs, Sterk, Peter J., Van Langenhove, Herman, Thas, Olivier, Van Cleemput, Joris, Nackaerts, Kristiaan, van Meerbeeck, Jan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710949/ https://www.ncbi.nlm.nih.gov/pubmed/29207669 http://dx.doi.org/10.18632/oncotarget.21335 |
Ejemplares similares
-
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
por: Janssens, Eline, et al.
Publicado: (2022) -
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
por: Janssens, Eline, et al.
Publicado: (2022) -
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
por: Schillebeeckx, Eline, et al.
Publicado: (2021) -
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
por: Lagniau, Sabrina, et al.
Publicado: (2017) -
The electronic nose: emerging biomarkers in lung cancer diagnostics
por: van Geffen, Wouter H., et al.
Publicado: (2019)